Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
223
-
Total 13F shares, excl. options
-
15.7M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$2.7B
-
Value change
-
+$283M
-
Put/Call ratio
-
0.18
-
Number of buys
-
104
-
Number of sells
-
-120
-
Price
-
$172.50
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q2 2017
264 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q2 2017.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 223 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.7M shares
of 24.7M outstanding shares and own 63.64% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.78M shares), JANUS HENDERSON GROUP PLC (1.43M shares), VANGUARD GROUP INC (1.3M shares), WELLINGTON MANAGEMENT GROUP LLP (634K shares), RENAISSANCE TECHNOLOGIES LLC (588K shares), WELLS FARGO & COMPANY/MN (556K shares), Champlain Investment Partners, LLC (503K shares), GW&K Investment Management, LLC (496K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (485K shares), and JPMORGAN CHASE & CO (418K shares).
This table shows the top 223 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.